Winner of the 2014 Frost & Sullivan Drug Delivery Technology Innovation Leadership Award

Frost & Sullivan Drug Delivery Technology Innovation Leadership Award

The award report concludes by saying: "ALRISE Biosystems GmbH is committed to deliver solutions optimising product life cycle management as well as enhancing performance of its partners' drugs in development. The innovative ImSus® technology's high encapsulation efficiency has the potential to make the drug development process efficient and simple. In view of these positive credentials, ALRISE Biosystems GmbH is a most deserving recipient of the Frost & Sullivan 2014 Technology Innovation Leadership Award in the European Drug Delivery Industry."

Download full report (PDF)
Download press release (PDF)

Award for the Business Case Presented at the Venture Lounge "Biotech" in Luxemburg on 30th April 2014

Business Case Presented at the Venture Lounge Biotech

ALRISE was invited to present their business case to a group of renowned strategic investors and VC companies. The jury of the Venture Lounge "Biotech" honoured ALRISE as second winner by stating: "The outstanding idea and the excellent presentation have convinced the jury. We warmly congratulate the team to this great success!"

Finalist of the Ernst & Young "Entrepreneur Of The Year" Awards 2008

Ernst & Young, Entrepreneur Of The Year Awards 2008

Recognised as one of the most prestigious business award programmes in the world, the Ernst & Young "Entrepreneur Of The Year" awards are granted to entrepreneurs in more than 60 countries. ALRISE, as one of the finalist, was honoured during a large gala dinner in Frankfurt on 9th October 2008 in the category of "privately owned, medium sized companies with potential for growth and innovation spirit."

ALRISE Biosystems GmbH
Robert-Roessle-Straße 10
Otto-Warburg-Haus
13125 Berlin, Germany
Phone +49 30.94 89 24 83
Fax +49 30.94 89 24 82
info@alrise.de